CARYSIL CARYSIL Q3 FY26 results (Oct–Dec 2025) and concall
Carysil reported a strong Q3 FY26 with consolidated total income growing 8.6% YoY to Rs. 225.2 crores and PAT surging 69.7% YoY to Rs. 21.3 crores, driven by significant EBITDA margin expansion to 19.4%. Volume growth was robust across key product categories. The company anticipates substantial export growth opportunities following new Free Trade Agreements and a reduced US tariff, which will allow for rolling back discounts and further margin improvement, despite a soft UK market.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q3 FY26: revenue up 9.9%, net profit up 61.5% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 |
|---|---|---|---|---|---|---|
| Revenue | 207 | 203 | 204 | 227 | 241 +16% | 223 +10% |
| EBITDA | 37 | 29 | 35 | 44 | 46 +24% | 42 +45% |
| Net profit | 17 | 13 | 19 | 23 | 27 +59% | 21 +62% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
